RESEARCH NOTE
·
One biotechnology company in the mid cap category.
One biotechnology company in the mid cap category.
Healthcare
Daily
ASX
This report is available to subscribers
The full research note — our view, the levels we are working to and the reasoning behind them — is part of a Kapitales subscription.